Bifidobacterium lactis Oral Dissolving Films

The representative probiotic concept uses a 10 billion CFU-per-film label benchmark and 30-film presentation found in marketed oral strips.

Category:

Oral-Films

Email:

thomasyan9733@vip.163.com

Pharmaceuticals:

+86-15230180709

Medical Devices:

+86-18603110901

Request a Quote

Description

产品描述

Bifidobacterium lactis Oral Dissolving Films
BAOTAI (HANGZHOU) PHARMACEUTICAL CO., LTD
Product ID: 10
PRODUCT CATEGORY
Probiotic representative
PRODUCT OVERVIEW
The representative probiotic concept uses a 10 billion CFU-per-film label benchmark and 30-film presentation found in marketed oral strips. The rendered BAOTAI product has not been tested to demonstrate this count.
FEATURED INGREDIENT
Bifidobacterium lactis; strain designation to be confirmed.
STRENGTH / POTENCY
10 Billion CFU per film
PACK CONFIGURATION
30 individually wrapped films per box; one film per sachet.
DOSAGE FORM
Oral dissolving film, shown as an individually sealed, thin rectangular strip. Film color and dimensions are illustrative.
DIRECTIONS STATUS
Daily intake, intended age group and product-specific instructions have not been finalized. Do not infer dose from the number of films in the box.
STORAGE AND SHELF LIFE
Temperature limits, moisture/light protection and shelf life must be established by stability testing of the final formulation in its final packaging.
FORMULATION ITEMS TO CONFIRM
Confirm strain identity, viable count through the end of shelf life, film-process survival, moisture and oxygen barriers, and storage conditions. Refrigeration requirements cannot be inferred from another product.
RANGE EXTENSIONS
Other planned probiotic variants: Streptococcus salivarius K12; Streptococcus salivarius M18; Limosilactobacillus reuteri (formerly Lactobacillus reuteri); Bacillus coagulans; Lacticaseibacillus rhamnosus (formerly Lactobacillus rhamnosus); other Bifidobacterium species; Lactobacillus acidophilus; and selected combinations. Strain identity and potency require confirmation for every variant. These are not all included in the displayed product.
PACKAGING DESIGN
NORTH BIOTECH logo; BAOTAI (HANGZHOU) PHARMACEUTICAL CO., LTD company line; blue, white and gold family style with a product-specific motif.
DOCUMENT STATUS
Packaging concept and English product-development information. Printed strengths are design benchmarks where specified; final formulation, permitted claims, directions and commercial specifications require confirmation. This is not an approved medicine leaflet.

FAQs

What main products does Baotai Pharmaceutical supply?

We provide human finished medicines, veterinary drugs, medical devices & consumables, pharmaceutical production equipment and professional technology transfer services.

Which countries and regions do you mainly export to?

Our business covers Southeast Asia, CIS countries, Africa, Middle East and Latin America, including Philippines, Uzbekistan, Vietnam, Ethiopia and more.

Does your company have international GMP qualification support?

Our team is proficient in EU-GMP and PICS regulations. We hold multiple overseas product registrations and assist factories in passing international GMP audits.

Can you help complete local drug registration in target countries?

Yes. We offer full-set overseas product registration application and approval consulting services for global clients.

What therapeutic areas do your human medicines focus on?

Our medicines mainly cover cardiovascular, antiviral, anti-tumor and other high-standard treatment fields.

Do you cooperate with formal domestic pharmaceutical manufacturers?

We maintain long-term stable partnerships with top Chinese pharmaceutical groups to guarantee product quality and supply stability.